These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 5385098)

  • 1. [Anabolic steroid preparations and blood coagulation system in patients with Cushing's disease].
    Vasiukova EA; Pisarskaia IB
    Klin Med (Mosk); 1969 Jul; 47(7):90-2. PubMed ID: 5385098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change in blood coagulation in Itsenko-Cushing's disease under the influence of chloditan treatment].
    Vasiukova EA; Pisarskaia IV
    Klin Med (Mosk); 1976 Aug; 54(8):108-10. PubMed ID: 1011762
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation in Cushing's and Addison's disease].
    Pisarskaia IV; Sharova IuA
    Sov Med; 1969 Aug; 32(8):118-21. PubMed ID: 5381906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of anabolic steroid preparations on blood coagulation processes].
    Karacharov AT
    Klin Med (Mosk); 1971 Oct; 49(10):131-4. PubMed ID: 5133136
    [No Abstract]   [Full Text] [Related]  

  • 5. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oxandrolone, an anabolic steroid, on hemostasis.
    Kahn NN; Sinha AK; Spungen AM; Bauman WA
    Am J Hematol; 2006 Feb; 81(2):95-100. PubMed ID: 16432848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The blood coagulation system and cortisol metabolism in Itsenko-Cushing disease].
    Vasiukova EA; Pisarskaia IV; Skvortsova RI
    Ter Arkh; 1969 Jul; 41(7):85-8. PubMed ID: 5374416
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological treatment of hypercortisolism.
    Shalet S; Mukherjee A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):234-8. PubMed ID: 18438170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cushing's syndrome. Case report of 43 patients with Cushing syndrome at the medical university clinic in Zurich in the years 1958-1969].
    Flury A; Müller J; Froesch ER; Labhart A
    Schweiz Med Wochenschr; 1971 Mar; 101(9):314-9. PubMed ID: 5546275
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical pharmacology of trienolones, a group of new anabolically actine aestrane-derivatives (4,9,11-oestratrien-17beta-ol-3-on)].
    Krüskemper HL; Morgner KD; Noell G
    Arzneimittelforschung; 1967 Apr; 17(4):449-54. PubMed ID: 5632439
    [No Abstract]   [Full Text] [Related]  

  • 13. Cushing's syndrome from Klack's solution.
    Lankford HV
    Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clotting changes in Cushing's syndrome: elevated factor VIII activity.
    Dal Bo Zanon R; Fornasiero L; Boscaro M; Ruffato G; Luzzato G; Fabris F; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):268-77. PubMed ID: 6194060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure responses to phenylephrine infusions in subjects with Cushing's syndrome.
    McKnight JA; Rooney DP; Whitehead H; Atkinson AB
    J Hum Hypertens; 1995 Oct; 9(10):855-8. PubMed ID: 8576903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of arterial hypertension in Cushing's syndrome].
    Rodrigues D; Barros L; Ruas L; Gomes L; Geraldes E; Ruas MC
    Acta Med Port; 1997 Nov; 10(11):785-7. PubMed ID: 9549109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation system changes in post-menopausal women receiving oestrogen preparations.
    Bonnar J; Haddon M; Hunter DH; Richards DH; Thornton C
    Postgrad Med J; 1976; 52 Suppl 6():30-6. PubMed ID: 981116
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of fibrinolytic and thrombolytic potential in the rat by an anabolic steroid, furazabol.
    Abiko Y; Kumada T
    Thromb Res; 1976 May; 8(2 suppl):107-14. PubMed ID: 936070
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation abnormalities associated with the use of anabolic steroids.
    Ansell JE; Tiarks C; Fairchild VK
    Am Heart J; 1993 Feb; 125(2 Pt 1):367-71. PubMed ID: 8427129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of the anabolic steroid, androstanasol, in patients with chronic gastritis].
    Trusov VV; Vakhrushev IaM
    Vrach Delo; 1973 Aug; 8():39-42. PubMed ID: 4771681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.